The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BL0020, a novel tumor microenvironment (TME)-targeting nano-mediated polypeptide-drug conjugate (NMPDC), in patients with advanced solid tumors: Updated results from the small cell lung cancer (SCLC) subset of a phase 1 study.
 
Shuhang Wang
No Relationships to Disclose
 
Charlotte Lemech
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Nanya Wang
No Relationships to Disclose
 
Xichun Hu
Honoraria - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Hengrui Pharmaceutical; Lilly; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca
 
Jian Zhang
No Relationships to Disclose
 
Michelle Morris
No Relationships to Disclose
 
Weixing Mao
No Relationships to Disclose
 
Haoyuan Jiang
No Relationships to Disclose
 
Fuyao Zhang
No Relationships to Disclose